Prevention of vasculopathy by vitamin K supplementation: can we turn fiction into fact?
about
Epigallocatechin Gallate: A Review of Its Beneficial Properties to Prevent Metabolic SyndromeNew Insights into the Pros and Cons of the Clinical Use of Vitamin K Antagonists (VKAs) Versus Direct Oral Anticoagulants (DOACs)Calcific uraemic arteriolopathy (calciphylaxis): data from a large nationwide registry.High-Dose Menaquinone-7 Supplementation Reduces Cardiovascular Calcification in a Murine Model of Extraosseous Calcification.Menaquinone-7 Supplementation to Reduce Vascular Calcification in Patients with Coronary Artery Disease: Rationale and Study Protocol (VitaK-CAC Trial).The effects of vitamin K supplementation and vitamin K antagonists on progression of vascular calcification: ongoing randomized controlled trialsA Nationally Representative Study of Calcific Uremic Arteriolopathy Risk Factors.CDKN2A/p16INK4a expression is associated with vascular progeria in chronic kidney disease.Lack of evidence does not justify neglect: how can we address unmet medical needs in calciphylaxis?Phenolic compounds analysis, antioxidant, and hepatoprotective effects of Periploca angustifolia extract on cadmium-induced oxidative damage in HepG2 cell line and rats.Plasma levels of vitamin K and the risk of ischemic heart disease: a Mendelian randomization study.Oral Anticoagulation in Chronic Kidney Disease and Atrial Fibrillation.The Effects of Parenteral K1 Administration in Pseudoxanthoma Elasticum Patients Versus Controls. A Pilot Study.A Novel Biomimetic Tool for Assessing Vitamin K Status Based on Molecularly Imprinted Polymers.
P2860
Q26801281-B97543C8-F8B2-4D83-80AA-F21F0FAACD18Q28081366-54C4199C-CAEC-43A3-A889-EAB158EE9BE9Q31048677-334878CF-FB7B-4E79-9069-129FD6CAFE46Q35752060-E4768513-5EAE-4011-9FF9-0339AC5D94A1Q36329772-D05D14AD-A85A-4AA5-9589-A4BD1910858CQ36689187-0C6B5E39-EBE7-40CD-ABC9-13903E00D8FDQ38801820-25C641E1-3F7B-42E8-82D4-F4935C082B15Q38964182-A233318F-5158-4AFC-BBD0-61925E5D0B22Q40837665-1E36F7C5-C6F2-4E03-AF30-1CC6F6BBC456Q46257904-95B0CBFD-DDE5-42FA-B7F0-8FB5C035B738Q50230145-BCBE0745-BB3A-429C-B793-91789DAA0BECQ55001247-357B7650-3A62-4E64-872C-E23847E0AEDAQ55328079-F07BF893-0004-487E-833A-240BAC2870A7Q55515203-D32B2E24-46B1-45CC-B869-1DF5A24A03F4
P2860
Prevention of vasculopathy by vitamin K supplementation: can we turn fiction into fact?
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
Prevention of vasculopathy by vitamin K supplementation: can we turn fiction into fact?
@en
type
label
Prevention of vasculopathy by vitamin K supplementation: can we turn fiction into fact?
@en
prefLabel
Prevention of vasculopathy by vitamin K supplementation: can we turn fiction into fact?
@en
P2093
P1433
P1476
Prevention of vasculopathy by vitamin K supplementation: can we turn fiction into fact?
@en
P2093
Georges Leftheriotis
Katrin Püsche
Nadine Kaesler
Rick H van Gorp
Sebastian Reinartz
Thilo Krüger
Vincent M Brandenburg
P356
10.1016/J.ATHEROSCLEROSIS.2015.02.040
P50
P577
2015-02-24T00:00:00Z